USFDA, Pharma and Alembic
Alembic Pharma shares jump 5% on final USFDA nod to Seizure treatment drug
This approval adds to Alembic Pharma's growing portfolio, which now includes 216 ANDA approvals from the USFDA, comprising 188 final approvals and 28 tentative approvals.
Alembic Pharma Gets US FDA Nod For Generic Medication To Treat Seizure
Lamotrigine extended-release tablets have an estimated market size of $163 million, as per data for twelve months ending June 2024, according to IQVIA.
Alembic Pharma share price gains 5% after USFDA okays seizures drug
Alembic Pharma share price surged after the United States Food and Drug Administration (USFDA) gave final approval for Lamotrigine ExtendedRelease Tablets USP, 200 mg, 250 mg, and 300 mg.
Alembic Pharma stock gains over 6% after USFDA approval for drug
The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.
Alembic Pharma jumps 4% on US FDA approves anti-seizure drug worth $163 million
The estimated market value for Lamotrigine Extended-Release Tablets is approximately $163 million for the year ending June 2024, according to IQVIA.
USDA gives nod to Alembic Pharma’s generic formulation to treat seizures
Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.
Alembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER
Vadodara: Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application
Alembic Pharma gets USFDA nod for generic medication
The approved ANDA is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR extended-release tablets in strength of 200 mg, 250 mg, and 300 mg, it added.
Drug Store News2d
Alembic receives FDA nod for 2 generics
The FDA has approved Alembic's generic Albenza and generic Invega. Alembic has received The Food and Drug Administration’s ...
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine Extended-Release Tablets USP, 200 mg, 250 ...
Mahindra, Max Life Insurance, Alembic Pharma take lead in PM internship scheme
Mahindra Group, Max Life Insurance, and Alembic Pharmaceuticals are leading internships under a new central scheme, with ...
Selected interns will be paid Rs 4,500 per month as stipend by the government through Direct Benefit Transfer (DBT).
Selected interns will be paid Rs 4,500 per month as stipend by the government through Direct Benefit Transfer (DBT).